PROMETHEUS BIOSCIENCES INC (RXDX)       108.68  +0.25 (+0.23%)

108.68  +0.25 (+0.23%)

US74349U1088 - Common Stock - After market: 108.68 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
1.12M1.23M
9.82%
3.129M
154.39%
6.864M
119.37%
EBITDA
-15.93M
-134.61%
-28.9M
-81.42%
-87.545M
-202.92%
-145.386M
-66.07%
N/AN/AN/AN/AN/AN/A
EBIT
-15.97M
-134.85%
-29.01M
-81.65%
-87.803M
-202.66%
-147.772M
-68.30%
Operating Margin
-1,425.89%-2,358.54%-2,806.10%-2,152.85%
EPS
N/AN/A-3.63-3.55
2.14%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS-0.92
-31.79%
-0.93
-20.81%
Revenue654.503K
-34.94%
552.024K
-46.77%
EBITDA-36.893M-41.188MN/AN/AN/AN/A
EBIT-37.299M
-39.21%
-41.304M
-37.94%

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 -0.90 -0.92 0.022.44% Q2 2022 -0.86 -0.93 0.077.69% Q1 2022 -0.82 -0.81 -0.01-1.40% Q4 2021 -0.77 -0.69 -0.08-11.30% Q3 2021 -0.70 -0.60 -0.10-17.11% Q2 2021 -0.49 -0.40 -0.09-23.60% Q1 2021 -1.67 -0.38 -1.29-341.31%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 968K 654.503K 313.497K47.90% Q2 2022 1.269M 520.649K 748.351K143.73% Q1 2022 3.919M 669.293K 3.25M485.54% Q4 2021 1.037M 554.584K 482.416K86.99% Q3 2021 1.006M 357K 649K181.79% Q2 2021 326K 153K 173K113.07% Q1 2021 760K 204K 556K272.55%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPS0% 2.05% 0% 1.01%
Revenue0% 2.01% 0% 11.95%